HRT Stock Overview
Designs, manufactures, and distributes clothing for children in Poland and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Hurtimex SA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | zł0.17 |
| 52 Week High | zł0.24 |
| 52 Week Low | zł0.12 |
| Beta | 1.04 |
| 11 Month Change | 23.19% |
| 3 Month Change | 23.19% |
| 1 Year Change | 1.80% |
| 33 Year Change | -14.14% |
| 5 Year Change | -15.00% |
| Change since IPO | -97.30% |
Recent News & Updates
Shareholder Returns
| HRT | PL Luxury | PL Market | |
|---|---|---|---|
| 7D | 15.6% | 6.9% | -0.2% |
| 1Y | 1.8% | 2.3% | 0.3% |
Return vs Industry: HRT matched the Polish Luxury industry which returned 2.3% over the past year.
Return vs Market: HRT exceeded the Polish Market which returned 0.3% over the past year.
Price Volatility
| HRT volatility | |
|---|---|
| HRT Average Weekly Movement | n/a |
| Luxury Industry Average Movement | 4.3% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in PL Market | 8.4% |
| 10% least volatile stocks in PL Market | 2.9% |
Stable Share Price: HRT's share price has been volatile over the past 3 months compared to the Polish market.
Volatility Over Time: Insufficient data to determine HRT's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1990 | 31 | Jaroslaw Kopec | www.hurtimex.com.pl |
Hurtimex SA designs, manufactures, and distributes clothing for children in Poland and internationally. Its products include skirts, blouses, sweaters, handkerchiefs, and gloves. The company sells its products under the Tup Tup, KANZ, Döll, Lemmi, Pampolina, and Königsmühle brand names.
Hurtimex SA Fundamentals Summary
| HRT fundamental statistics | |
|---|---|
| Market cap | zł5.57m |
| Earnings (TTM) | -zł480.01k |
| Revenue (TTM) | zł15.25m |
0.4x
P/S Ratio-11.6x
P/E RatioIs HRT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HRT income statement (TTM) | |
|---|---|
| Revenue | zł15.25m |
| Cost of Revenue | zł10.25m |
| Gross Profit | zł5.00m |
| Other Expenses | zł5.48m |
| Earnings | -zł480.01k |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.015 |
| Gross Margin | 32.81% |
| Net Profit Margin | -3.15% |
| Debt/Equity Ratio | 49.6% |
How did HRT perform over the long term?
See historical performance and comparison